Skip to content
    Drishti.money
    Earnings calls

    Alkem Lab concall ledger

    Every earnings call for ALKEM — management tone, guidance, KPIs and promise tracking, quarter by quarter.

    ALKEM · 5 transcripts · Healthcare · latest Q3 FY26
    Q3 FY26Published 13 Feb 2026Call held 13 Feb 2026

    ALKEM Q3 FY26 Earnings Call Transcript & Analysis

    Total Revenue37,368 million+11% YoYEBITDA8,280 million+9% YoYEBITDA Margin22.2%Net Profit6,360 million+2% YoYPBT7,812 million+7% YoY

    Total Revenue 37368 million (+11% YoY); EBITDA 8280 million (+9% YoY); EBITDA Margin 22.2%. Total revenue grew 10.7% YoY to INR 37,368 million.

    Read full transcript & analysis
    Q1 FY26Published 12 Aug 2025Call held 12 Aug 2025

    ALKEM Q1 FY26 Earnings Call Transcript & Analysis

    Total Revenue33,711 million+11% YoYEBITDA7,391 million+21% YoYEBITDA Margin21.9%Net Profit6,643 million+22% YoY

    Total Revenue 33711 million (+11% YoY); EBITDA 7391 million (+21% YoY); EBITDA Margin 21.9%. Total revenue from operations stood at INR33,711 million with Y-o-Y growth of 11.2%.

    Read full transcript & analysis
    Q3 FY25Published 07 Feb 2025Call held 07 Feb 2025

    ALKEM Q3 FY25 Earnings Call Transcript & Analysis

    Revenue from Operations33,743 million+2% YoYEBITDA7,594 million+7% YoYEBITDA Margin22.5%Net Profit6,258 million+5% YoY

    Revenue from Operations 33743 million (+2% YoY); EBITDA 7594 million (+7% YoY); EBITDA Margin 22.5%. Revenue from operations for Q3 FY25 was INR33,743 million, with a 1.5% YoY growth.

    Read full transcript & analysis